Multisystem Inflammatory Syndrome in Children (MIS-C): Difference between revisions

(MIS -C)
mNo edit summary
Line 104: Line 104:
# Abdominal ultrasound – colitis, ileitis, lymphadenopathy, ascites, hepatosplenomegaly  
# Abdominal ultrasound – colitis, ileitis, lymphadenopathy, ascites, hepatosplenomegaly  
# CT chest – as for chest x ray – may demonstrate coronary artery abnormalities if with contrast<ref name=":2">https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf</ref> <br>  
# CT chest – as for chest x ray – may demonstrate coronary artery abnormalities if with contrast<ref name=":2">https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf</ref> <br>  
== Outcome Measures  ==
add links to outcome measures here (see [[Outcome Measures|Outcome Measures Database]])


== Management / Interventions<br>  ==
== Management / Interventions<br>  ==


add text here relating to management approaches to the condition<br>  
<br>  


== Differential Diagnosis<br>  ==
== Differential Diagnosis<br>  ==

Revision as of 16:16, 17 November 2021

Original Editor - User Name
Top Contributors - Rishika Babburu

Introduction[edit | edit source]

A multisystem inflammatory syndrome in children (MIS-C) is associated with coronavirus disease 2019.[1]Since December 2019, the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has resulted in high morbidity and mortality worldwide. One of the most intriguing and mysterious phenomena observed during the COVID-19 pandemic has been represented by the occurrence of the multisystem inflammatory syndrome in children and adolescents (MIS-C).[2] Multisystem inflammatory disorder in children (MIS-C) most commonly affects young, school-aged children and is characterized by persistent fever, systemic hyperinflammation, and multisystem organ dysfunction.[3] In early May, the United Kingdom and several European countries reported the occurrence of a hyperinflammatory process in children that had features similar to atypical Kawasaki’s disease, Kawasaki’s disease shock syndrome, and toxic shock syndrome, possibly related to SARS-CoV-2 infection.[4][5][6]Patients with this condition have some overlapping signs and symptoms with those of Kawasaki disease (KD), but also display clinical features that are uncommon or less frequent in this illness, such as diarrhea, abdominal pain and myocardial involvement. The sickest patients may develop multiorgan failure and shock, usually due to myocarditis.[2]

Clinically Relevant Anatomy[edit | edit source]

add text here relating to clinically relevant anatomy of the condition

Pathological Process[edit | edit source]

The pathophysiology of MIS-C is not well understood.

Immune dysregulation – It has been suggested that the syndrome results from an abnormal immune response to the virus, with some clinical similarities to Kawasaki disease (KD), macrophage activation syndrome (MAS), and cytokine release syndrome. However, based on the available studies, MIS-C appears to have an immunophenotype that is distinct from KD and MAS. The exact mechanisms by which SARS-CoV-2 triggers the abnormal immune response are unknown.Preliminary studies suggest that patients with severe MIS-C have persistent immunoglobulin G (IgG) antibodies with enhanced ability to activate monocytes, persistent cytopenias (particularly T cell lymphopenia), and greater activation of CD8+ T cells that differ from findings in acute COVID-19 infection.[7]

SARS-CoV-2 virus – Many affected children have negative polymerase chain reaction (PCR) testing for SARS-CoV-2 but have positive serology, a finding that further supports the hypothesis that MIS-C is related to immune dysregulation occurring after acute infection has passed. However, some children do have positive PCR testing.[7]

Clinical Presentation[edit | edit source]

All:

  • Persistent fever >38.5°C

Most:

  • Oxygen requirement
  • Hypotension

Some:

  • Abdominal pain
  • Confusion
  • Conjunctivitis
  • Cough
  • Diarrhoea
  • Headache
  • Lymphadenopathy
  • Mucus membrane changes
  • Neck swelling
  • Rash
  • Respiratory symptoms
  • Sore throat
  • Swollen hands and feet
  • Syncope
  • Vomiting

Investigations[edit | edit source]

  • Full Blood Count
  • Urea and electrolytes
  • Liver function test
  • Glucose
  • Blood gas with lactate
  • Coagulation + fibrinogen
  • D-Dimer
  • Lactate Dehydrogenase(LDH)
  • Triglycerides
  • Ferritin
  • Troponin
  • Pro-BNP
  • Creatine Kinase(CK)
  • Vitamin D
  • Amylase
  • Urinalysis
  • Save EDTA and serum for PCR and serological studies (ideally pre IVIG)
  • Blood culture
  • Urine and Stool culture
  • Throat swab culture
  • NPA or throat swab for respiratory panel plus SARS-CoV-2 PCR
  • Stool and blood for SARS-CoV-2 PCR
  • Pneumococcal, Meningococcal, Group A strep, Staph aureus Blood PCR
  • Antistreptolysin O titer (ASOT)
  • SARS-CoV-2 serology
  • EBV, CMV, Adenovirus, Enterovirus PCR on blood
  • Stool for virology

Laboratory Findings[edit | edit source]

  • Abnormal Fibrinogen
  • Absence of potential causative organisms (other than SARS-CoV-2)
  • High CRP
  • High D-Dimers
  • High ferritin
  • Hypoalbuminaemia
  • Lymphopenia
  • Neutrophilia in most – normal neutrophils in some
  • Acute kidney injury
  • Anaemia
  • Coagulopathy
  • Neutrophilia
  • Proteinuria
  • Raised CK
  • Raised LDH
  • Raised triglycerides
  • Raised troponin
  • Thrombocytopenia
  • Transaminitis

Imaging and ECG[edit | edit source]

  1. Echo and ECG – myocarditis, valvulitis, pericardial effusion, coronary artery dilatation
  2. Chest X Ray – patchy symmetrical infiltrates, pleural effusion
  3. Abdominal ultrasound – colitis, ileitis, lymphadenopathy, ascites, hepatosplenomegaly
  4. CT chest – as for chest x ray – may demonstrate coronary artery abnormalities if with contrast[8]

Management / Interventions
[edit | edit source]


Differential Diagnosis
[edit | edit source]

This rare syndrome shares common features with other paediatric inflammatory conditions including: Kawasaki disease, staphylococcal and streptococcal toxic shock syndromes, bacterial sepsis and macrophage activation syndromes. It can also present with unusual abdominal symptoms with excessive inflammatory markers.[8]

Resources
[edit | edit source]

add appropriate resources here

References[edit | edit source]

  1. https://www.nejm.org/doi/full/10.1056/NEJMoa2021756#article_references
  2. 2.0 2.1 https://www.frontiersin.org/articles/10.3389/fped.2021.680813/full#B1
  3. https://www.sciencedirect.com/science/article/pii/S1876034121000125
  4. Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 2020;10:537-540.
  5. European Centre for Disease Prevention and Control. Rapid risk assessment: paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. May 15, 2020
  6. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020;395:1771-1778.
  7. 7.0 7.1 https://www.uptodate.com/contents/covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis
  8. 8.0 8.1 https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf